Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Congressional ’07 Budget Proposal Would Limit CDER Capabilities – FDA

This article was originally published in The Tan Sheet

Executive Summary

President Bush's 2008 budget request for FDA includes spending $11.2 million more than proposed in Congress' 2007 omnibus spending bill for a "modernizing drug safety" initiative, including work by offices within the Center for Drug Evaluation and Research

You may also be interested in...



Planned ORA Reorganization Could Move 100 Investigators To Field

As many as 100 investigators will move to field positions as part of the proposed reorganization of FDA's Office of Regulatory Affairs, Commissioner Andrew von Eschenbach said April 12

Planned ORA Reorganization Could Move 100 Investigators To Field

As many as 100 investigators will move to field positions as part of the proposed reorganization of FDA's Office of Regulatory Affairs, Commissioner Andrew von Eschenbach said April 12

Planned ORA Reorganization Could Move 100 Investigators To Field

As many as 100 investigators will move to field positions as part of the proposed reorganization of FDA's Office of Regulatory Affairs, Commissioner Andrew von Eschenbach said April 12

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS100203

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel